Last reviewed · How we verify
TISSEEL Lyo
TISSEEL Lyo is a fibrin sealant used to control bleeding.
TISSEEL Lyo is a fibrin sealant used to control bleeding. Used for Control of bleeding from surgical incisions or injuries.
At a glance
| Generic name | TISSEEL Lyo |
|---|---|
| Also known as | Fibrin sealant Vapor Heated, Solvent/Detergent-Treated, with 500 IU/mL Thrombin |
| Sponsor | Baxter Healthcare Corporation |
| Drug class | Fibrin sealant |
| Modality | Biologic |
| Therapeutic area | Surgical Hemostasis |
| Phase | Phase 3 |
Mechanism of action
It works by forming a fibrin clot to stop bleeding from surgical incisions or injuries. The product contains fibrinogen and thrombin, which are essential components in the coagulation cascade.
Approved indications
- Control of bleeding from surgical incisions or injuries
Common side effects
- Hypersensitivity reactions
Key clinical trials
- Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct to Haemostasis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TISSEEL Lyo CI brief — competitive landscape report
- TISSEEL Lyo updates RSS · CI watch RSS
- Baxter Healthcare Corporation portfolio CI